chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: M
Vaccine: FLUX, PPV
Symptoms: Sleep disorder
Clinical narrative: This is a non-serious spontaneous case, initially received from health authority (reported to health authority by other non-health professional) (VAERS ID: 708916) on 10-Dec-2017, concerning a 70-year-old, elderly, male patient. On 17-Aug-2017, the patient was administered with influenza vaccine (route of administration: injection (reported as SYR), anatomical location: left arm, dose, batch number, expiry date, trade name, manufacturer: not reported). On the same day, the patient was administered with non-company suspect vaccine PNEUMOVAX (anatomical location: left arm, route of administration: SYR (as reported), dose, batch number, expiry date: not reported). On the same day, about 5 hours after vaccination, the patient had severe pain in his left arm at the site of the two injections. It was a throbbing pain that prevented him from sleeping. Hence, he took 250 mg Ibuprofen. During night, he experienced chills, fever and had sleep disturbance. By next morning, he felt better. However, arm was still sore to touch at the injection site though there was no longer throbbing pain. The outcome of the events (throbbing pain, sleep disturbance, limb discomfort, injection site pain, chills and fever) was recovered. The reporter assessed the events as non-serious.
Sex: F
Vaccine: FLUX, PNC13
Symptoms: Injection site swelling
Clinical narrative: This spontaneous case, reported by a pharmacist to VAERS and initially retrieved on 03-Feb-2018 by Seqirus from VAERS (VAERS ID: 716703), concerns a female patient of unspecified age. The patient's relevant medical history or current illness and concomitant medications were not reported. On an unspecified date, the patient was administered with influenza vaccine (dose: UNK (as reported), anatomical location, route of administration, batch number, expiry date, trade name, manufacturer: not reported) and the patient was administered with non-company suspect product, PREVNAR 13 (dose: UNK (as reported), route of administration, anatomical location, batch number, expiry date: not reported). On an unspecified date after vaccination, the patient experienced swelling at the injection site that lasted for 5 to 7 days. At the time of this report, the outcome of the event-injection site swelling was unknown. The reporter assessed this case as non-serious.
Sex: F
Vaccine: FLUX
Symptoms: Asthenia, Chest discomfort, Chest pain, Cold sweat, Diarrhoea
Clinical narrative: This spontaneous case, initially received from regulatory authority (VAERS ID: 719728) (reported to RA by other non-health professional_ on 10-Dec-2017 and concerns a 20-year-old, adult, female patient. The patient was allergic to morphine and concomitant medication included LESSINA. On 10-Oct-2017, the patient was administered with INN flu vaccine (route of administration:injection, anatomical location, dose, manufacturer, trade name, batch number, expiry date: not reported). On 10-Oct-2017, Tuesday (as reported) at 11 PM, after 10 hours of vaccination, the patient felt very achy, weak and had trouble sleep all night and constant movement. On 11-Oct-2017, Wednesday (as reported) at 7:30 AM, the patient still had aches all over her body and was very lightheaded. It was reported that she went to work and remained lightheaded while moving and slight nausea. She had diarrhoea twice at evey half-hour, during the day. On the same day at 11 PM, she had very difficult in sleep and extreme tightness on her chest which made worsen when laid down and had left side pain to throughout arm. On 12-Oct-2017, Thursday (as reported) at 2:17 AM, she treated with Ibuprofen 200 mg four circular tables (as reported), later the pain in both arms and chest were subsided but nausea exist which was easier to breathe (as reported) and burping so often. She still had the body aches, hot, cold sweats and weakness with opening doors and sore muscles. The outcome of the events nausea, burping, pain, hot and cold sweaats were not recovered and chest discomfort, asthenea, weakness, sore muscles, diarhoea, insomnia, lightheaded and pain in extremity were recovered. The reporter assessed the events as non-serious and causality of the events asthenia and pain as related to suspect vaccine.
Sex: F
Vaccine: FLUX
Symptoms: Dizziness, Eructation, Feeling hot, Insomnia, Myalgia
Clinical narrative: This spontaneous case, initially received from regulatory authority (VAERS ID: 719728) (reported to RA by other non-health professional_ on 10-Dec-2017 and concerns a 20-year-old, adult, female patient. The patient was allergic to morphine and concomitant medication included LESSINA. On 10-Oct-2017, the patient was administered with INN flu vaccine (route of administration:injection, anatomical location, dose, manufacturer, trade name, batch number, expiry date: not reported). On 10-Oct-2017, Tuesday (as reported) at 11 PM, after 10 hours of vaccination, the patient felt very achy, weak and had trouble sleep all night and constant movement. On 11-Oct-2017, Wednesday (as reported) at 7:30 AM, the patient still had aches all over her body and was very lightheaded. It was reported that she went to work and remained lightheaded while moving and slight nausea. She had diarrhoea twice at evey half-hour, during the day. On the same day at 11 PM, she had very difficult in sleep and extreme tightness on her chest which made worsen when laid down and had left side pain to throughout arm. On 12-Oct-2017, Thursday (as reported) at 2:17 AM, she treated with Ibuprofen 200 mg four circular tables (as reported), later the pain in both arms and chest were subsided but nausea exist which was easier to breathe (as reported) and burping so often. She still had the body aches, hot, cold sweats and weakness with opening doors and sore muscles. The outcome of the events nausea, burping, pain, hot and cold sweaats were not recovered and chest discomfort, asthenea, weakness, sore muscles, diarhoea, insomnia, lightheaded and pain in extremity were recovered. The reporter assessed the events as non-serious and causality of the events asthenia and pain as related to suspect vaccine.
Sex: F
Vaccine: FLUX
Symptoms: Nausea, Pain, Pain in extremity, Restlessness
Clinical narrative: This spontaneous case, initially received from regulatory authority (VAERS ID: 719728) (reported to RA by other non-health professional_ on 10-Dec-2017 and concerns a 20-year-old, adult, female patient. The patient was allergic to morphine and concomitant medication included LESSINA. On 10-Oct-2017, the patient was administered with INN flu vaccine (route of administration:injection, anatomical location, dose, manufacturer, trade name, batch number, expiry date: not reported). On 10-Oct-2017, Tuesday (as reported) at 11 PM, after 10 hours of vaccination, the patient felt very achy, weak and had trouble sleep all night and constant movement. On 11-Oct-2017, Wednesday (as reported) at 7:30 AM, the patient still had aches all over her body and was very lightheaded. It was reported that she went to work and remained lightheaded while moving and slight nausea. She had diarrhoea twice at evey half-hour, during the day. On the same day at 11 PM, she had very difficult in sleep and extreme tightness on her chest which made worsen when laid down and had left side pain to throughout arm. On 12-Oct-2017, Thursday (as reported) at 2:17 AM, she treated with Ibuprofen 200 mg four circular tables (as reported), later the pain in both arms and chest were subsided but nausea exist which was easier to breathe (as reported) and burping so often. She still had the body aches, hot, cold sweats and weakness with opening doors and sore muscles. The outcome of the events nausea, burping, pain, hot and cold sweaats were not recovered and chest discomfort, asthenea, weakness, sore muscles, diarhoea, insomnia, lightheaded and pain in extremity were recovered. The reporter assessed the events as non-serious and causality of the events asthenia and pain as related to suspect vaccine.
Sex: F
Vaccine: FLUX
Symptoms: Hypersensitivity, Urticaria
Clinical narrative: This spontaneous, reported by health care professional (other) to VAERS and initially retrieved on 03-Feb-2018 by Seqirus from VAERS (VAERS ID: 720004), concerns a 33-year-old, adult, female patient. The patient had seasonal allergies. On 10-Oct-2017, the patient was administered with INN flu vaccine (route of administration: intramuscular, anatomical location: left arm, dose, batch number, expiry date, trade name and manufacture: not reported). On 11-Oct-2017, 1 day after vaccination, the patient developed hives on whole body (full body). On 12-Oct-2017, the patient consulted family physician, given schedule for antihistamine and steroids for allergic reaction. At the time of this report, the outcome of the events was not recovered. The reporter assessed this case as non-serious.
Age: 13.0
Sex: M
Vaccine: FLUX
Symptoms: Headache, Pyrexia
Clinical narrative: This is a spontaneous case, initially received from FDA (VAERS ID: 721128) (reported to HA by other non-health professional) on 03-Feb-2018, concerning a 13-year-old adolescent male patient. The patient's current conditions included iodine dye allergy and asthma like illnesses. The patient's concomitant medications included SINGULAIR, Multivitamin and Vitamin D for an unknown indication. On 16-Oct-2017, the patient was administered with influenza vaccine (route of administration: injection (reported as SYR), anatomical location: (RA) right arm, dose, batch number, expiry date, manufacturer and trade name: not reported). On 17-Oct-2017, after 02 days of vaccination, the patient had a headache, fever of 101-degree F and fever increased overnight and reached 102-degree F. It was reported that, after 12-13 hours (unspecified date in Oct-2017), fever had subsided. The patient recovered from the events headache and fever. The reporter assessed the events as non-serious.
Sex: F
Vaccine: FLUX
Symptoms: Urticaria
Clinical narrative: This spontaneous case, reported by non-healthcare professional (other) to VAERS and initially retrieved on 03-Feb-2018 by Seqirus from VAERS (VAERS ID: 722160), concerns a 03-year-old, female child. The patient had no history/allergies, concomitant medications or current conditions. The patient had no exposure to anything new or pets at home. On 04-Oct02917, the patient was administered with INN Flu Vaccine Seasonal (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer). On 05-Oct-2017, next day of vaccination, the patient developed hives and was taken to the physician. The patient was given unspecified steroid drink for the treatment of hives and was advised with ZYRTEC and BENADRYL as needed. The patient's mother reported that, hives re-occurred if the medicine was skipped. The patient visited the physician again (next week) and scrap test was done. It was told that, the patient was recovering, even thought urticaria had spread from limbs to whole body. On an unspecified date (reported as last week), the patient was take to an allergist and was diagnosed with demographic Urticaria. The patient was prescribed with ZYRTEC at night and morning. Initially, for 3 days patient was free from urticaria, nevertheless the patient developed urticaria when the medicine was missed (morning dose). It was reported that, it was almost 3 weeks, but the event had not resolved. The reporter assessed the case as non-serious.
Age: 58.0
Sex: F
Vaccine: FLUX, VARZOS
Symptoms: Rash erythematous
Clinical narrative: This is a spontaneous case, reported by other non-healthcare professional (patient) to VAERS and initially retrieved on 03-Feb-2018 by Seqirus from VAERS (VAERS ID: 722749), concerning a 58-year-old, adult, female patient. The patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 04-Oct-2017, the patient was administered with influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). On the same day, the patient was also administered with non-company suspect drug ZOSTAVAX (dose, route of administration, anatomical location, batch number, expiry date: not reported). It was reported that, both the vaccines were administered at the same spot. On 06-Oct-2017, after 2 days of vaccination, the patient noticed a red rash forming which was not bumpy. The patient did not seek any medical attention and her laboratory data was unknown. The patient had not yet recovered from the event rash erythematous. The reporter assessed the events as non-serious.
Age: 76.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Hypersensitivity
Clinical narrative: This spontaneous case, reported by non-healthcare professional (other) to VAERS and initially retrieved on 03-Feb-2018 by Seqirus from VAERS (VAERS ID: 722919), concerns a 76-year-old, elderly, female patient. The patient's medical history and current conditions were not reported. On an unspecified date, the patient was administered with influenza vaccine (dose, route of administration, anatomical location, manufacturer, tradename, batch number and expiry date: not reported). On the same day, the patient was administered with non-company suspect product, PNEUMOVAX (dose, route of administration, anatomical location, manufacturer, tradename, batch number and expiry date: not reported). On an unspecified date, the patient had hypersensitivity reaction. At the time of the event, the outcome of the event (hypersensitivity) was not reported. The reporter assessed the event as non-serious.
Age: 51.0
Sex: M
Vaccine: FLUX
Symptoms: Cold sweat, Dyspnoea
Clinical narrative: This spontaneous case, reported by pharmacist to VAERS and initially retrieved on 03-Feb-2018 by Seqirus from VAERS (VAERS ID: 723125), concerns a 51-year-old, adult, male patient. The patient had no medical history and was not taking any concomitant medications. On an unspecified date in 1985, the patient was administered with influenza vaccine and felt sick. On 28-Nov-2018, the patient was administered with influenza vaccine, dose: 1 (as reported), route of administration: injection, anatomical location: arm, manufacturer, tradename, batch number and expiry date: not reported). On 30-Nov-2018, after 2 days of vaccination, the patient had shortness of breath and cold sweat. On 15-Dec-2018, after a couple of weeks, the patient had recovered from the events (cold sweat and shortness of breath). The reporter assessed the case as non-serious.
Age: 34.0
Sex: M
Vaccine: FLUX
Symptoms: Injection site pain, Mobility decreased, Pain in extremity
Clinical narrative: This is a spontaneous case, reported by other health professional to VAERS and initially retrieved on 03-Feb-2018 by Seqirus from VAERS (VAERS: 727742), concerning 34-year-old, male patient. The patient had no medical history. The patient was not taking any concomitant medications. On 03-Oct-2017, the patient was administered with influenza vaccine (dose: unk, route of administration, anatomical location, trade name, batch number and expiry date: not reported). On the same day, after administration of vaccine, the patient felt pain at site of flu vaccination below boney prominence. It was reported that the patient's left (L) arm was continued to be painful for last 4 weeks, because of which he had reduced motion in raising and reaching. The patient was referred with occupational medicine for the events. The outcome of the events was not reported. The reporter assessed the events as non-serious.
Age: 0.83
Sex: U
Vaccine: FLUX, PNC13
Symptoms: Pyrexia, Rash
Clinical narrative: This is spontaneous case, reported by other non-healthcare professional (consumer) to VAERS and initially retrieved on 03-Feb-2018 by Seqirus from VAERS (VAERS ID: 729318), concerns a 10 month old infant of unspecified gender. On an unspecified date, the patient was administered twice with pneumococcal, diphtheria crm 197 protein (route, dose, batch number, expiry date: not reported). The patient's current condition and concomitant medications were not reported. On an unspecified date, the patient was administered with INN Flu Vaccine Seasonal (route of administration: intramuscular, dose: unknown, anatomical site, manufacturer name, trade name, batch number and expiry date: not reported). On an unspecified date, the patient was also administered with PREVNAR 13 (dose:3 (as reported), route: unknown, anatomical site, manufacturer name, trade name, batch number and expiry date: not reported). On an unspecified date, the patient had fever and received TYLENOL, which caused the fever to be subside. On an unspecified date, the patient experienced skin rash. The outcome of the event was reported as recovered and for the event skin rash it was not reported. The reporter assessed this case as non-serious.
Age: 30.0
Sex: M
Vaccine: JEV1, JEV1
Symptoms: Injection site erythema, Injection site haemorrhage
Clinical narrative: Within 12-24hrs the injection site had palm sized redness (picture shows violaceous macular lesion) and mild swelling with an irregular border and fine papular eruption. Area became dusky colored over several days like a healing bruise and then resolved. No pain. No itchiness.
Age: 30.0
Sex: M
Vaccine: JEV1, JEV1
Symptoms: Injection site discolouration, Injection site erythema, Injection site macule, Injection site reaction, Injection site swelling
Clinical narrative: Within 12-24hrs the injection site had palm sized redness (picture shows violaceous macular lesion) and mild swelling with an irregular border and fine papular eruption. Area became dusky colored over several days like a healing bruise and then resolved. No pain. No itchiness.
Age: 30.0
Sex: M
Vaccine: JEV1, JEV1
Symptoms: Rash papular, Skin test negative
Clinical narrative: Within 12-24hrs the injection site had palm sized redness (picture shows violaceous macular lesion) and mild swelling with an irregular border and fine papular eruption. Area became dusky colored over several days like a healing bruise and then resolved. No pain. No itchiness.
Age: 61.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Injection site bruising, Rash, Rash erythematous, Rash pruritic
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of generalized rash in a 61-year-old male patient who received SHINGRIX (batch number 9XC39, expiry date January 2020). On 16th February 2018, the patient received the 1st dose of SHINGRIX (intramuscular). In February 2018, 7 days after receiving SHINGRIX, the patient experienced generalized rash. On an unknown date, the outcome of the generalized rash was recovering/resolving. The reporter considered the generalized rash to be probably related to SHINGRIX. Additional details were provided as follows: Health care professional reported that the patient had generalized body rash 1 week after the dose of SHINGRIX (left arm). Health care professional stated the lot number might be 9XC39 but most likely 9XC34. Health care professional did not have full date of vaccine expiration. Health care professional stated the adverse event was reported to VAERS but not to GSK until time of reporting. The reported batch number (9XC34) for SHINGRIX did not exist and was updated to 9XC39 as per sales database.
Age: 61.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Rash generalised
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of generalized rash in a 61-year-old male patient who received SHINGRIX (batch number 9XC39, expiry date January 2020). On 16th February 2018, the patient received the 1st dose of SHINGRIX (intramuscular). In February 2018, 7 days after receiving SHINGRIX, the patient experienced generalized rash. On an unknown date, the outcome of the generalized rash was recovering/resolving. The reporter considered the generalized rash to be probably related to SHINGRIX. Additional details were provided as follows: Health care professional reported that the patient had generalized body rash 1 week after the dose of SHINGRIX (left arm). Health care professional stated the lot number might be 9XC39 but most likely 9XC34. Health care professional did not have full date of vaccine expiration. Health care professional stated the adverse event was reported to VAERS but not to GSK until time of reporting. The reported batch number (9XC34) for SHINGRIX did not exist and was updated to 9XC39 as per sales database.
Age: 68.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Incorrect route of drug administration, Injection site erythema, Injection site induration, Injection site pain, Injection site warmth
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of pain in a 68-year-old female patient who received SHINGRIX (batch number 79N59, expiry date 30th January 2020). On 20th March 2018, the patient received the 1st dose of SHINGRIX (subcutaneous) .5 ml. On 20th March 2018, unknown after receiving SHINGRIX, the patient experienced intramuscular formulation administered by other route. On 21st March 2018, the patient experienced pain, swelling and feeling of warmth. On an unknown date, the outcome of the pain, swelling and feeling of warmth were not recovered/not resolved and the outcome of the intramuscular formulation administered by other route was unknown. The reporter considered the pain, swelling and feeling of warmth to be related to SHINGRIX. Additional details were provided as follows: The healthcare professional stated that the patient was inadvertently administered SHINGRIX in the left arm subcutaneously. This led to inappropriate route of vaccination. One day after receiving vaccination, the patient experience pain, warmth, and swelling. The health care professional stated that a doctor visit was required, and the patient was going to see the doctor on 23rd March 2018, Friday.
Age: 68.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Feeling hot, Incorrect route of drug administration, Pain, Rash, Swelling
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of pain in a 68-year-old female patient who received SHINGRIX (batch number 79N59, expiry date 30th January 2020). On 20th March 2018, the patient received the 1st dose of SHINGRIX (subcutaneous) .5 ml. On 20th March 2018, unknown after receiving SHINGRIX, the patient experienced intramuscular formulation administered by other route. On 21st March 2018, the patient experienced pain, swelling and feeling of warmth. On an unknown date, the outcome of the pain, swelling and feeling of warmth were not recovered/not resolved and the outcome of the intramuscular formulation administered by other route was unknown. The reporter considered the pain, swelling and feeling of warmth to be related to SHINGRIX. Additional details were provided as follows: The healthcare professional stated that the patient was inadvertently administered SHINGRIX in the left arm subcutaneously. This led to inappropriate route of vaccination. One day after receiving vaccination, the patient experience pain, warmth, and swelling. The health care professional stated that a doctor visit was required, and the patient was going to see the doctor on 23rd March 2018, Friday.
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Fever; using acetominiphen.
Age: 56.0
Sex: M
Vaccine: FLU4
Symptoms: Lymphadenopathy, Lymphoma
Clinical narrative: This case was reported by a physician via sales rep and described the occurrence of lymphoma in a male patient who received FLULAVAL Quadrivalent (batch number K5T45, expiry date 31st May 2018). On 19th September 2017, the patient received FLULAVAL Quadrivalent. On an unknown date, less than a year after receiving FLULAVAL Quadrivalent, the patient experienced lymphoma (serious criteria GSK medically significant) and lymphadenopathy. On an unknown date, the outcome of the lymphoma and lymphadenopathy were unknown. The reporter considered the lymphoma and lymphadenopathy to be almost certainly related to FLULAVAL Quadrivalent. Additional details were reported as follows: The age at vaccination was not reported. The diagnosis date was not known.
Age: 1.25
Sex: F
Vaccine: HIBV, MMR, PNC13, VARCEL
Symptoms: Crying, Irritability, Middle insomnia, Poor quality sleep, Pruritus
Clinical narrative: She has a red rash on her face, neck, back and stomach. She's irritable and itchy and, she has started waking up around 2 am each night (3 consecutive nights) crying, squealing and rolling around for an hour until falling back asleep then whining in her sleep.
Age: 1.25
Sex: F
Vaccine: HIBV, MMR, PNC13, VARCEL
Symptoms: Rash, Rash erythematous
Clinical narrative: She has a red rash on her face, neck, back and stomach. She's irritable and itchy and, she has started waking up around 2 am each night (3 consecutive nights) crying, squealing and rolling around for an hour until falling back asleep then whining in her sleep.
Age: 1.42
Sex: M
Vaccine: DTAPIPVHIB, FLU4, HEP, HEPA, MMR, PNC13, VARCEL
Symptoms: Pyrexia, Rash generalised
Clinical narrative: Patient developed fever on day 10 after vaccines, started with full body rash on day 11 post vaccines.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Headache, fever, chills, upset stomach, muscle aches.
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Injection site pain, Myalgia
Clinical narrative: Patient experienced pain on injection site for four days, myalgia and shivering 2 days after injection was given.
Age: 53.0
Sex: F
Vaccine: HEPA
Symptoms: Injection site rash
Clinical narrative: Localized Rash near area of injection.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Hypersensitivity, Pyrexia, Rash erythematous
Clinical narrative: Patient complaints of "allergic reaction" s/p receiving second dose of SHINGRIX vaccine on 3/25/2018.  Patient states she noted a pruritic rash to her face and chest that she "thought was pimples" on 3/27/18. Patient also reports of onset of headache, fever, chills, and tachycardia started the evening of 3/25/18 and that which lasted until 3/26/18. Patient states she has taken Claritin and Cortisone cream for her symptoms, and has reported her symptoms to GlaxoSmith&Kline. On exam patient without signs and symptoms of distress. Exam unremarkable except for a rash present: multiple small pinpoint erythematous prutitic maculopapular pustular rash present to left mandible, extending to left upper lip, close to left nare. 2 small pinpoint erythematous maculopapular rash to right maxilla. 1 small pinpoint erythematous maculopapular rash to left upper chest present. At visit complete, patient sent  home with recommendations to return to clinic in 24 hrs; instructed to go to ER or Urgent Care center if symptoms worsen, and instructed to go to Opthalmology immediately if rash extends to eye or eye becomes reddened or painful.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash maculo-papular, Rash pruritic, Tachycardia
Clinical narrative: Patient complaints of "allergic reaction" s/p receiving second dose of SHINGRIX vaccine on 3/25/2018.  Patient states she noted a pruritic rash to her face and chest that she "thought was pimples" on 3/27/18. Patient also reports of onset of headache, fever, chills, and tachycardia started the evening of 3/25/18 and that which lasted until 3/26/18. Patient states she has taken Claritin and Cortisone cream for her symptoms, and has reported her symptoms to GlaxoSmith&Kline. On exam patient without signs and symptoms of distress. Exam unremarkable except for a rash present: multiple small pinpoint erythematous prutitic maculopapular pustular rash present to left mandible, extending to left upper lip, close to left nare. 2 small pinpoint erythematous maculopapular rash to right maxilla. 1 small pinpoint erythematous maculopapular rash to left upper chest present. At visit complete, patient sent  home with recommendations to return to clinic in 24 hrs; instructed to go to ER or Urgent Care center if symptoms worsen, and instructed to go to Opthalmology immediately if rash extends to eye or eye becomes reddened or painful.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Pain, Pruritus, Rash pustular
Clinical narrative: Noticed raised welts on 3/24 or 3/25 on my left shoulder/upper chest, which spread to an area of 2 inches by 3 inches and by 3/25 or 3/26 turned into blisters. Also have 2 smaller areas of blisters, one on my upper left back and the other lower on my left chest area. Looks like I have shingles. Area is itchy/irritating and somewhat painful. Went back to pharmacist on 3/26, but there only advice was to visit my doctor if it continued to bother me. I have not  visited a doctor and rash is currently still bothering me. It looks blistered with puss.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Skin irritation, Urticaria
Clinical narrative: Noticed raised welts on 3/24 or 3/25 on my left shoulder/upper chest, which spread to an area of 2 inches by 3 inches and by 3/25 or 3/26 turned into blisters. Also have 2 smaller areas of blisters, one on my upper left back and the other lower on my left chest area. Looks like I have shingles. Area is itchy/irritating and somewhat painful. Went back to pharmacist on 3/26, but there only advice was to visit my doctor if it continued to bother me. I have not  visited a doctor and rash is currently still bothering me. It looks blistered with puss.
Age: 1.33
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Adverse drug reaction, Candida infection, Cyst, Diarrhoea, Discomfort
Clinical narrative: We first noticed her lymph node swelling on the right side of her neck approximentally 02/17/2017 where it had swelled roughly the size of a dime with no dis-coloration. It could have been swollen sooner, but gone unoticed. I waited around 7 weeks before taking her in since it didn't grow very much in size at first, she had no symptoms like fever, or pain in the area when it was touched or rubbed, and we honestly contributed it to allergy season. However, it started to swell more, so I took her in first 04/07/2017, where they assumed allergies as well at the time being, and prescribed Cetirizine HCI 1MG/ML which we gave her as directed. It's important to note that on this visit, they also went ahead and gave her the HEP A VAC PED/ADOL, 2DOSE INTRAMU (90633). After this visit, her node began to more rapidly swell, started showing red discoloration and she started showing some discomfort. We took her in again, a week or so later, (I can't find the paperwork when exactly) and they prescribed Clindamycin Palmitate HCI 75MG/5ML which we took as directed for the course of time directed. We brought her back in 04/27/2017 where they started her on Amoxicillin-Pot Clavulanate 600-42.9MG/5ML, which we started giving as directed, but after 5 days I stopped it after it gave her thrush, made her more irritable, and I simply wasn't convinced it, or the previous medication was working, and wanted better answers as to why this may be happening. We were then sent to Medical Center at their ENT department to see NP where they prescribed taking Clarithromycin (BIAXIN) 50 MG/ML until her appointment with Dr. on 05/17/2017. I was still insistant that medication wasn't working, as it kept giving her diarrhea, thrush, and horrible rashes, and wanted a hospital visit to find out what was wrong since everyone seemed stumped. I asked of course, if it had anything to do with vaccines, but the notion was shut down by every doctor I asked. We were admitted to the Medical Center. After several tests, to include a sonogram, they still couldn't determine what caused the reaction, but concluded it wasn't systemic, which is why medications weren't working, and essentially the lymph node had become like a cyst. We were told to give her Azithromycin 40 MG/ML for 4 days, which I did as directed, and to allow the node (which at this point was about the size of a silver dollar and completely red with some purple, and seemed to cause discomfort when we touched it.) to simpy pop and drain on its own. Which it did a few days later in the middle of the night. Dr. recommended a type of cosmetic surgery upon our visit to him on 05/17/2017, which I turned down. Since then, we've been instructed to let it heal on its own, and "see what it does". No one still seems to know or accept what truly caused it in the first place, or what any long term damage might be yet, and it hasn't been further addressed since the follow-up appointment after the hospital visit. No more vaccines, or medications have been administered to pt since.
Age: 1.33
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Erythema, Irritability, Lymphadenopathy, Rash, Secretion discharge
Clinical narrative: We first noticed her lymph node swelling on the right side of her neck approximentally 02/17/2017 where it had swelled roughly the size of a dime with no dis-coloration. It could have been swollen sooner, but gone unoticed. I waited around 7 weeks before taking her in since it didn't grow very much in size at first, she had no symptoms like fever, or pain in the area when it was touched or rubbed, and we honestly contributed it to allergy season. However, it started to swell more, so I took her in first 04/07/2017, where they assumed allergies as well at the time being, and prescribed Cetirizine HCI 1MG/ML which we gave her as directed. It's important to note that on this visit, they also went ahead and gave her the HEP A VAC PED/ADOL, 2DOSE INTRAMU (90633). After this visit, her node began to more rapidly swell, started showing red discoloration and she started showing some discomfort. We took her in again, a week or so later, (I can't find the paperwork when exactly) and they prescribed Clindamycin Palmitate HCI 75MG/5ML which we took as directed for the course of time directed. We brought her back in 04/27/2017 where they started her on Amoxicillin-Pot Clavulanate 600-42.9MG/5ML, which we started giving as directed, but after 5 days I stopped it after it gave her thrush, made her more irritable, and I simply wasn't convinced it, or the previous medication was working, and wanted better answers as to why this may be happening. We were then sent to Medical Center at their ENT department to see NP where they prescribed taking Clarithromycin (BIAXIN) 50 MG/ML until her appointment with Dr. on 05/17/2017. I was still insistant that medication wasn't working, as it kept giving her diarrhea, thrush, and horrible rashes, and wanted a hospital visit to find out what was wrong since everyone seemed stumped. I asked of course, if it had anything to do with vaccines, but the notion was shut down by every doctor I asked. We were admitted to the Medical Center. After several tests, to include a sonogram, they still couldn't determine what caused the reaction, but concluded it wasn't systemic, which is why medications weren't working, and essentially the lymph node had become like a cyst. We were told to give her Azithromycin 40 MG/ML for 4 days, which I did as directed, and to allow the node (which at this point was about the size of a silver dollar and completely red with some purple, and seemed to cause discomfort when we touched it.) to simpy pop and drain on its own. Which it did a few days later in the middle of the night. Dr. recommended a type of cosmetic surgery upon our visit to him on 05/17/2017, which I turned down. Since then, we've been instructed to let it heal on its own, and "see what it does". No one still seems to know or accept what truly caused it in the first place, or what any long term damage might be yet, and it hasn't been further addressed since the follow-up appointment after the hospital visit. No more vaccines, or medications have been administered to pt since.
Age: 1.33
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Ultrasound scan
Clinical narrative: We first noticed her lymph node swelling on the right side of her neck approximentally 02/17/2017 where it had swelled roughly the size of a dime with no dis-coloration. It could have been swollen sooner, but gone unoticed. I waited around 7 weeks before taking her in since it didn't grow very much in size at first, she had no symptoms like fever, or pain in the area when it was touched or rubbed, and we honestly contributed it to allergy season. However, it started to swell more, so I took her in first 04/07/2017, where they assumed allergies as well at the time being, and prescribed Cetirizine HCI 1MG/ML which we gave her as directed. It's important to note that on this visit, they also went ahead and gave her the HEP A VAC PED/ADOL, 2DOSE INTRAMU (90633). After this visit, her node began to more rapidly swell, started showing red discoloration and she started showing some discomfort. We took her in again, a week or so later, (I can't find the paperwork when exactly) and they prescribed Clindamycin Palmitate HCI 75MG/5ML which we took as directed for the course of time directed. We brought her back in 04/27/2017 where they started her on Amoxicillin-Pot Clavulanate 600-42.9MG/5ML, which we started giving as directed, but after 5 days I stopped it after it gave her thrush, made her more irritable, and I simply wasn't convinced it, or the previous medication was working, and wanted better answers as to why this may be happening. We were then sent to Medical Center at their ENT department to see NP where they prescribed taking Clarithromycin (BIAXIN) 50 MG/ML until her appointment with Dr. on 05/17/2017. I was still insistant that medication wasn't working, as it kept giving her diarrhea, thrush, and horrible rashes, and wanted a hospital visit to find out what was wrong since everyone seemed stumped. I asked of course, if it had anything to do with vaccines, but the notion was shut down by every doctor I asked. We were admitted to the Medical Center. After several tests, to include a sonogram, they still couldn't determine what caused the reaction, but concluded it wasn't systemic, which is why medications weren't working, and essentially the lymph node had become like a cyst. We were told to give her Azithromycin 40 MG/ML for 4 days, which I did as directed, and to allow the node (which at this point was about the size of a silver dollar and completely red with some purple, and seemed to cause discomfort when we touched it.) to simpy pop and drain on its own. Which it did a few days later in the middle of the night. Dr. recommended a type of cosmetic surgery upon our visit to him on 05/17/2017, which I turned down. Since then, we've been instructed to let it heal on its own, and "see what it does". No one still seems to know or accept what truly caused it in the first place, or what any long term damage might be yet, and it hasn't been further addressed since the follow-up appointment after the hospital visit. No more vaccines, or medications have been administered to pt since.
Age: 68.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Vaccination site swelling
Clinical narrative: On 20 March she received her PCV13 (first dose) and now notes localized redness and swelling of her left shoulder at/around vaccination site for the past 24 hours. She denies constitutional and systemic symptoms. No prior adverse vaccine reactions.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Dizziness, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Patient reports pain, redness, swelling up the right shoulder and down the elbow, fever, lightheadedness, dizziness, shivering lasting 2-5 days after injection was given.
Age: 2.0
Sex: M
Vaccine: HEPA
Symptoms: Pyrexia, Vomiting
Clinical narrative: Patient with fever > 102 and emesis.
Age: 20.0
Sex: M
Vaccine: HEPA
Symptoms: Wrong drug administered
Clinical narrative: Patient was given the Hepatitis A vaccine when they needed to receive the Hepatitis B vaccine.
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: Activated partial thromboplastin time shortened, Alanine aminotransferase normal, Aspartate aminotransferase normal, Blood albumin normal, Blood bilirubin normal
Clinical narrative: Patient developed symptoms of aseptic meningitis the evening of vaccination.
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: Blood calcium normal, Blood chloride normal, Blood creatinine normal, Blood glucose normal, Blood magnesium increased
Clinical narrative: Patient developed symptoms of aseptic meningitis the evening of vaccination.
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: Blood phosphorus decreased, Blood potassium normal, Blood sodium decreased, Blood urea normal, CSF glucose decreased
Clinical narrative: Patient developed symptoms of aseptic meningitis the evening of vaccination.
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: CSF lactate increased, CSF lymphocyte count increased, CSF monocyte count decreased, CSF neutrophil count, CSF protein increased
Clinical narrative: Patient developed symptoms of aseptic meningitis the evening of vaccination.
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: CSF red blood cell count positive, CSF white blood cell count increased, Carbon dioxide normal, Gram stain, HIV test negative
Clinical narrative: Patient developed symptoms of aseptic meningitis the evening of vaccination.
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: Haematocrit normal, Haemoglobin normal, International normalised ratio increased, Meningitis aseptic, Protein total increased
Clinical narrative: Patient developed symptoms of aseptic meningitis the evening of vaccination.
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: Red blood cell count normal, Red blood cell sedimentation rate normal, White blood cell count increased
Clinical narrative: Patient developed symptoms of aseptic meningitis the evening of vaccination.
Age: 72.0
Sex: F
Vaccine: PPV
Symptoms: Injected limb mobility decreased, Injection site induration, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Left arm became itchy and began swelling at injection site around 2:00 pm on 3/22/18. Within 3 hours, the entire upper arm was swollen, hard, very sore, and hot to the touch. The flesh around the injection site was raised. The swelling extended past the elbow by Friday morning (3/23/2018). The arm was yellow in color by Saturday (3/24/2018). We called the doctor's office around 4 pm on 3/22/18 and again around 10 am on 3/23/18. Both times they recommended taking my mother to the ER. We opted NOT to do that given her advanced age and recent bout with bronchitis. We did not wish to expose her to anything in the ER. Her breathing was not impacted by the swelling in her arm. But her range of motion in her left arm was very restricted due to the intense swelling and soreness. Swelling in the arm persisted until 3/27/2018. The arm is still yellow as of this posting. There is no bruising.
Age: 72.0
Sex: F
Vaccine: PPV
Symptoms: Injection site warmth, Peripheral swelling, Skin discolouration
Clinical narrative: Left arm became itchy and began swelling at injection site around 2:00 pm on 3/22/18. Within 3 hours, the entire upper arm was swollen, hard, very sore, and hot to the touch. The flesh around the injection site was raised. The swelling extended past the elbow by Friday morning (3/23/2018). The arm was yellow in color by Saturday (3/24/2018). We called the doctor's office around 4 pm on 3/22/18 and again around 10 am on 3/23/18. Both times they recommended taking my mother to the ER. We opted NOT to do that given her advanced age and recent bout with bronchitis. We did not wish to expose her to anything in the ER. Her breathing was not impacted by the swelling in her arm. But her range of motion in her left arm was very restricted due to the intense swelling and soreness. Swelling in the arm persisted until 3/27/2018. The arm is still yellow as of this posting. There is no bruising.
Age: 59.0
Sex: M
Vaccine: PPV, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Pt's left arm is red, painful, and warm from deltoid to elbow.
Age: 52.0
Sex: F
Vaccine: FLUC4
Symptoms: Dizziness, Injected limb mobility decreased, Injection site discomfort, Injection site hypoaesthesia, Injection site pain
Clinical narrative: Patient came in on 3/28/18 1245pm to report and adverse reaction (SIRVA-Brusitis) from the vaccine she received on 1/26/18. She reports that almost immediately she felt a severe pain at the injection site while she was shopping and almost passed out from the pain. She also reports that it went numb and it felt like dead weight. She began to take ibuprofen and it seemed to go away but till this day she has restricted motion in her left arm and cannot raise it too high. she has an appointment with her doctor this week since the pain and discomfort has been ongoing. Informed patient to let us know how it goes or if she needs anything else from us as well as reassured her that we would be reporting this adverse event.
Age: 52.0
Sex: F
Vaccine: FLUC4
Symptoms: Limb discomfort, Vaccination complication
Clinical narrative: Patient came in on 3/28/18 1245pm to report and adverse reaction (SIRVA-Brusitis) from the vaccine she received on 1/26/18. She reports that almost immediately she felt a severe pain at the injection site while she was shopping and almost passed out from the pain. She also reports that it went numb and it felt like dead weight. She began to take ibuprofen and it seemed to go away but till this day she has restricted motion in her left arm and cannot raise it too high. she has an appointment with her doctor this week since the pain and discomfort has been ongoing. Informed patient to let us know how it goes or if she needs anything else from us as well as reassured her that we would be reporting this adverse event.
Age: 1.5
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Blood culture, Body temperature decreased, Culture urine, Feeling cold, Full blood count
Clinical narrative: Pt with core temperature of 95.5 rectally. Evaluated by ED. Warmed with warm blankets.  No hypoperfusion. Discharged home after work up.
Age: 1.5
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Metabolic function test
Clinical narrative: Pt with core temperature of 95.5 rectally. Evaluated by ED. Warmed with warm blankets.  No hypoperfusion. Discharged home after work up.
Age: 68.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site reaction, Rash erythematous
Clinical narrative: Red rash widespread on upper left arm.
Age: 79.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain, Back pain, Constipation, Herpes zoster, Post herpetic neuralgia
Clinical narrative: Four days after vaccine pt developed lower back pain, then abd pain, constipation. On 3/19 she developed painful rash right anterior thigh/buttock and right suprapubic area. Seen in ofc 3/20 and had classic Herpes zoster rash. Treated with oral valcyclovir and on follow-up 3/28 rash is improving, but has 10/10 post-herpetic neuralgia. To begin gabapentin 100 mg tid and return for f/u 2-3 weeks.
Age: 79.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Four days after vaccine pt developed lower back pain, then abd pain, constipation. On 3/19 she developed painful rash right anterior thigh/buttock and right suprapubic area. Seen in ofc 3/20 and had classic Herpes zoster rash. Treated with oral valcyclovir and on follow-up 3/28 rash is improving, but has 10/10 post-herpetic neuralgia. To begin gabapentin 100 mg tid and return for f/u 2-3 weeks.
Age: 77.0
Sex: U
Vaccine: VARZOS
Symptoms: Therapeutic response unexpected
Clinical narrative: Pt developed a benign ganglion cyst on the wrist in October 2015, doctor's could not determine cause. Pt. says within 48 hours of vaccine, the cyst had fully disappeared.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Dry mouth, Erythema, Headache, Hypersomnia
Clinical narrative: Shot was given at yearly physical 3-22-18 at 3:30 PM, woke up 5:30 AM 3-23-18 with a fever of 101.5 swollen face with bright red cheeks and forehead, headache, sore upper body, nausea, dry mouth, light headed, teeth on left side of mouth hurt. Slept all day except to use the bathroom. Broke fever at 12:49 PM 3-23-18 (98.9).
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Nausea, Pain, Pyrexia, Swelling face, Toothache
Clinical narrative: Shot was given at yearly physical 3-22-18 at 3:30 PM, woke up 5:30 AM 3-23-18 with a fever of 101.5 swollen face with bright red cheeks and forehead, headache, sore upper body, nausea, dry mouth, light headed, teeth on left side of mouth hurt. Slept all day except to use the bathroom. Broke fever at 12:49 PM 3-23-18 (98.9).